rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2-3
|
pubmed:dateCreated |
1994-6-23
|
pubmed:abstractText |
120 patients with chronic gastritis and primary chronic gastroduodenitis were given a three-week course of etiopathogenetic treatment (antichelibacterial and immunocorrective drugs) that allowed to diminish the clinical, bacteriological and immune manifestations of the disease and achieve a complete cure in most patients. Patients with marked chelibacteriosis revealed greater refractoriness. The authors recommend prolonged courses of treatment with alternations of etiologically directed drugs.
|
pubmed:language |
rus
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1019-5297
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
121-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8191708-Adjuvants, Immunologic,
pubmed-meshheading:8191708-Adolescent,
pubmed-meshheading:8191708-Adult,
pubmed-meshheading:8191708-Anti-Bacterial Agents,
pubmed-meshheading:8191708-Antibodies, Bacterial,
pubmed-meshheading:8191708-Autoimmune Diseases,
pubmed-meshheading:8191708-Chronic Disease,
pubmed-meshheading:8191708-Drug Therapy, Combination,
pubmed-meshheading:8191708-Duodenitis,
pubmed-meshheading:8191708-Female,
pubmed-meshheading:8191708-Gastritis,
pubmed-meshheading:8191708-Helicobacter Infections,
pubmed-meshheading:8191708-Helicobacter pylori,
pubmed-meshheading:8191708-Humans,
pubmed-meshheading:8191708-Male,
pubmed-meshheading:8191708-Middle Aged
|
pubmed:articleTitle |
[The etiotropic and pathogenetic treatment of patients with chronic gastritis and primary chronic gastroduodenitis].
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|